Literature DB >> 3865649

Apo E allele frequency in primary endogenous hypertriglyceridemia (type IV) with and without hyperapobetalipoproteinemia.

S Lussier-Cacan, D Bouthillier, J Davignon.   

Abstract

Apolipoprotein E polymorphism is responsible for the existence in the population of six apo E phenotypes determined by three alleles acting at a single gene locus. We have previously reported an enrichment in the epsilon 2 allele and the E2-bearing phenotypes in an unselected sample of subjects with primary hyperlipidemia consisting mainly of endogenous hypertriglyceridemia (Type IV). A study was carried out on 214 Type IV hypertriglyceridemic subjects to determine whether there was the same distribution in subjects with hyperapobetalipoproteinemia as in those without. The study showed that the relative enrichment in the epsilon 2 allele was associated only with Type IV subjects without hyperapobetalipoproteinemia. Since hyperapobetalipoproteinemia is a presumed marker for familial combined hyperlipidemia (FCHL), this finding may provide further evidence that FCHL and familial hypertriglyceridemia, both associated with a Type IV lipoprotein pattern, are truly separate disease entities.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865649     DOI: 10.1161/01.atv.5.6.639

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  3 in total

1.  Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.

Authors:  J Davignon; D Bouthillier; A C Nestruck; C F Sing
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

2.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

Authors:  C Bétard; A M Kessling; M Roy; A Chamberland; S Lussier-Cacan; J Davignon
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.

Authors:  J Davignon; R Dufour; M Roy; C Bétard; Y Ma; S Ouellette; L Boulet; S Lussier-Cacan
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.